305 results on '"Wichmann, Christian"'
Search Results
2. Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993
3. Correction to: Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993
4. CD74 is a functional MIF receptor on activated CD4+ T cells
5. A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis model
6. Real world outcomes, healthcare utilisation and costs of Alzheimer's disease in England
7. Rescreening on RBANS Delayed Memory Index? Forget About It!
8. Osmotic properties of T cells determined by flow imaging microscopy in comparison to electrical sensing zone analysis
9. Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2
10. Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo
11. Receiving, Handling, Storage, Thawing, Distribution, and Administration of CAR-T Cells Shipped from the Manufacturing Facility
12. Defined Human Leukemic CD34+ Liquid Cultures to Study HDAC/Transcriptional Repressor Complexes
13. Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes
14. Understanding opalescence measurements of biologics – A comparison study of methods, standards, and molecules
15. Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation
16. Radiolabelling and preclinical characterisation of [89Zr]Zr-Df-ATG-101 bispecific to PD-L1/4–1BB.
17. Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of 225Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models.
18. CD74 is a functional MIF receptor on activated CD4+ T cells.
19. GFI1 is required for RUNX1/ETO positive acute myeloid leukemia
20. Enhanced potency of immunotherapy against B‐cell precursor acute lymphoblastic leukemia by combination of an Fc‐engineered CD19 antibody and CD47 blockade
21. Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX
22. Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa
23. CLIA Updates
24. The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300‐dependent stemness program.
25. Oncological impact of perioperative blood transfusion in bladder cancer patients undergoing radical cystectomy: Do we need to consider storage time of blood units, donor age, or gender matching?
26. Real‐world use and cost of health and social care services of 18,116 patients living with Alzheimer’s disease
27. Osmotic behavior of t cells determined by flow imaging microscopy
28. PP140 Burden of Illness And Health Care Costs In People with Alzheimer’s Disease
29. CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI Inhibition
30. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia
31. ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells
32. Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis Sets.
33. Deciphering Acute Myeloid Leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem/Progenitor Cells.
34. Oncological impact of perioperative blood transfusion in bladder cancer patients undergoing radical cystectomy: Do we need to consider storage time of blood units, donor age, or gender matching?
35. Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis Sets
36. Kompatible Blutkonserven bei Sichelzellkrankheit und multiplen Alloantikörpern – ein Fallbericht
37. Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo
38. PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study
39. Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion
40. Purified recombinant lentiviral Vpx proteins maintain their SAMHD1 degradation efficiency in resting CD4+ T cells
41. Predictive value of molecular matching tools for the development of donor specific HLA ‐antibodies in patients undergoing lung transplantation
42. Synthesis and validation of [18F]mBPET-1, a fluorine-18 labelled mTOR inhibitor derivative based on a benzofuran backbone
43. Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells
44. Supplementary Figure 2 from Targeting the Oligomerization Domain of ETO Interferes with RUNX1/ETO Oncogenic Activity in t(8;21)-Positive Leukemic Cells
45. Supplementary Figure 4 from Targeting the Oligomerization Domain of ETO Interferes with RUNX1/ETO Oncogenic Activity in t(8;21)-Positive Leukemic Cells
46. Supplementary Figure 3 from Targeting the Oligomerization Domain of ETO Interferes with RUNX1/ETO Oncogenic Activity in t(8;21)-Positive Leukemic Cells
47. Supplementary Figure 1 from Targeting the Oligomerization Domain of ETO Interferes with RUNX1/ETO Oncogenic Activity in t(8;21)-Positive Leukemic Cells
48. Additional file 2 of Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo
49. Additional file 1 of Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo
50. Membrane permeability of Jurkat cells to cryoprotective agents determined by flow imaging microscopy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.